Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Dow
UBS
Citi
US Army
McKinsey
Medtronic
Cerilliant
Harvard Business School

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for Patent: RE29668

« Back to Dashboard

Summary for Patent: RE29668
Title: Glycineamides
Abstract:A process for the synthesis of N-aryl-3,4-dihydro-2-alkyl-4-oxo-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxides by treatment of N-aryl-N'-alkyl-N'-(2'-alkoxycarbonylbenzenesulfonyl)glycineamides, useful intermediates for said process, with an alkali or alkaline earth metal hydride in a reaction-inert solvent at 50.degree.-150.degree. C., said products being antiinflammatory agents. .Iadd.
Inventor(s): Lombardino; Joseph G. (Niantic, CT)
Assignee: Pfizer Inc. (New York, NY)
Application Number:05/780,312
Patent Claim Types:
see list of patent claims
Compound; Process;

Drugs Protected by US Patent RE29668

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent RE29668

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 205249 ➤ Sign Up
Austria 333777 ➤ Sign Up
Austria A327374 ➤ Sign Up
Canada 1018525 ➤ Sign Up
Switzerland 590257 ➤ Sign Up
Czechoslovakia 165311 ➤ Sign Up
German Democratic Republic 111079 ➤ Sign Up
Denmark 140014 ➤ Sign Up
Spain 425398 ➤ Sign Up
Finland 52087 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Boehringer Ingelheim
Dow
Covington
Deloitte
QuintilesIMS
Citi
Fuji
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot